Skip to main content
logo
CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
11.13
-0.49 (-4.22%)
At close: Oct 31, 2025, 4:00 PM EDT
11.18
+0.05 (0.45%)
After-hours: Oct 31, 2025, 7:49 PM EDT

CorMedix Revenue

CorMedix had revenue of $39.74M in the quarter ending June 30, 2025, with 4,829.40% growth. This brings the company's revenue in the last twelve months to $121.48M, up 14,970.29% year-over-year. In the year 2024, CorMedix had annual revenue of $43.47M.

Revenue (ttm)
$121.48M
Revenue Growth
+14,970.29%
P/S Ratio
5.81
Revenue / Employee
$1,868,992
Employees
65
Market Cap
872.03M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202443.47M--
Dec 31, 2023---
Dec 31, 202265.41K-125.53K-65.74%
Dec 31, 2021190.94K-48.30K-20.19%
Dec 31, 2020239.23K-44.04K-15.55%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
Eli Lilly and Company59.42B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Novo Nordisk49.11B
Revenue Rankings

CRMD News

More News